• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . Host-dependent editing of SARS-CoV-2 in COVID-19 patients

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2021 Aug 17;1-50.
doi: 10.1080/22221751.2021.1969868. Online ahead of print.
Host-dependent editing of SARS-CoV-2 in COVID-19 patients


Josep Gregori[SUP] 1 2 3 [/SUP], Maria Francesca Cortese[SUP] 4 [/SUP], Maria Piñana[SUP] 5 [/SUP], Carolina Campos[SUP] 1 2 [/SUP], Damir Garcia-Cehic[SUP] 1 2 [/SUP], Cristina Andrés[SUP] 5 [/SUP], Josep Francesc Abril[SUP] 6 [/SUP], Maria Gema Codina[SUP] 7 [/SUP], Ariadna Rando[SUP] 7 [/SUP], Juliana Esperalba[SUP] 7 [/SUP], Elena Sulleiro[SUP] 7 [/SUP], Joan Joseph[SUP] 7 [/SUP], Narcis Saubí[SUP] 7 [/SUP], Sergi Colomer-Castell[SUP] 1 [/SUP], Mari Carmen Martin[SUP] 5 [/SUP], Carla Castillo[SUP] 5 [/SUP], Juan Ignacio Esteban[SUP] 1 [/SUP], Tomas Pumarola[SUP] 7 8 [/SUP], Francisco Rodriguez-Frias[SUP] 2 4 8 [/SUP], Andrés Antón[SUP] 5 8 [/SUP], Josep Quer[SUP] 1 2 [/SUP]



Affiliations

Abstract

Introduction: A common trait among RNA viruses is their high capability to acquire genetic variability due to viral and host mechanisms. Next-generation sequencing (NGS) analysis enables deep study of the viral quasispecies in samples from infected individuals.
Methods: In this study, the viral quasispecies complexity and single nucleotide polymorphisms of the SARS-CoV-2 spike gene of coronavirus disease 2019 (COVID-19) patients with mild or severe disease was investigated using next-generation sequencing (Illumina platform).
Results: SARS-CoV-2 spike variability was higher in patients with long-lasting infection. Most substitutions found were present at frequencies lower than 1%, and had an A → G or T → C pattern, consistent with variants caused by adenosine deaminase acting on RNA-1 (ADAR1). ADAR1 affected a small fraction of replicating genomes, but produced multiple, mainly non-synonymous mutations.
Conclusions: ADAR1 editing during replication rather than the RNA-dependent RNA polymerase (nsp12) was the predominant mechanism generating SARS-CoV-2 genetic variability. However, the mutations produced are not fixed in the infected human population, suggesting that ADAR1 may have an antiviral role, whereas nsp12-induced mutations occurring in patients with high viremia and persistent infection are the main source of new SARS-CoV-2 variants.

Keywords: ADAR1; SARS-CoV-2; editing; mutations; quasispecies.
 
Back
Top Bottom